| scholarly article | Q13442814 |
| P2093 | author name string | Dong Wook Ryang | |
| Jong Hee Shin | |||
| Kyungwon Lee | |||
| Mi-Na Kim | |||
| Myung Geun Shin | |||
| Soo Hyun Kim | |||
| Soon Pal Suh | |||
| Eui-Chong Kim | |||
| Sook-In Jung | |||
| Kyung Hwa Park | |||
| Seung Jung Kee | |||
| Heungsup Sung | |||
| Jin-Sol Lee | |||
| Namhee Ryoo | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Candida haemulonii | Q118202949 |
| P304 | page(s) | e57-61 | |
| P577 | publication date | 2009-03-01 | |
| P1433 | published in | Clinical Infectious Diseases | Q5133764 |
| P1476 | title | Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features | |
| P478 | volume | 48 |
| Q91655102 | A case report of infectious scleritis with corneal ulcer caused by Scedosporium aurantiacum |
| Q50083987 | A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance. |
| Q89080678 | A rare fungus on the rise: Candida auris |
| Q34778312 | Accuracy of species-level identification of yeast isolates from blood cultures from 10 university hospitals in South Korea by use of the matrix-assisted laser desorption ionization-time of flight mass spectrometry-based Vitek MS system |
| Q40119738 | Antifungal Potential of Copper(II), Manganese(II) and Silver(I) 1,10-Phenanthroline Chelates Against Multidrug-Resistant Fungal Species Forming the Candida haemulonii Complex: Impact on the Planktonic and Biofilm Lifestyles. |
| Q34086897 | Antifungal drug discovery: the process and outcomes |
| Q35112435 | Antifungal susceptibilities of bloodstream isolates of Candida species from nine hospitals in Korea: application of new antifungal breakpoints and relationship to antifungal usage |
| Q41987164 | Approach to the investigation and management of patients with Candida auris, an emerging multidrug-resistant yeast |
| Q28084765 | Are the Conventional Commercial Yeast Identification Methods Still Helpful in the Era of New Clinical Microbiology Diagnostics? A Meta-Analysis of Their Accuracy |
| Q40562624 | Breakthrough invasive fungal diseases during voriconazole treatment for aspergillosis: A 5-year retrospective cohort study |
| Q92339644 | Candida auris Isolates of the Southern Asian and South African Lineages Exhibit Different Phenotypic and Antifungal Susceptibility Profiles In Vitro |
| Q89510130 | Candida auris, an Agent of Hospital-Associated Outbreaks: Which Challenging Issues Do We Need to Have in Mind? |
| Q51149128 | Candida auris, what do paediatricians need to know? |
| Q42712931 | Candida auris-associated candidemia, South Africa |
| Q89944189 | Candida auris: A Decade of Understanding of an Enigmatic Pathogenic Yeast |
| Q33704302 | Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally |
| Q48220845 | Candida auris: A systematic review and meta-analysis of current updates on an emerging multidrug-resistant pathogen |
| Q46255772 | Candida auris: An Emerging Fungal Pathogen |
| Q39092282 | Candida auris: a worrisome, globally emerging pathogen |
| Q37007553 | Candida duobushaemulonii: an emerging rare pathogenic yeast isolated from recurrent vulvovaginal candidiasis in Brazil. |
| Q44061564 | Candida haemulonii complex: species identification and antifungal susceptibility profiles of clinical isolates from Brazil |
| Q42741161 | Candida haemulonii species complex: an emerging species in India and its genetic diversity assessed with multilocus sequence and amplified fragment-length polymorphism analyses |
| Q57466099 | Candidemia due to uncommon Candida species in children: new threat and impacts on outcomes |
| Q38477531 | Catheter-related candidemia caused by Candida haemulonii in a patient in long-term hospital care |
| Q90610965 | Clade II Candida auris possess genomic structural variations related to an ancestral strain |
| Q92320618 | Combined Antifungal Resistance and Biofilm Tolerance: the Global Threat of Candida auris |
| Q28829671 | Comparative Pathogenicity of United Kingdom Isolates of the Emerging Pathogen Candida auris and Other Key Pathogenic Candida Species |
| Q35915352 | Comparison of E,E-Farnesol Secretion and the Clinical Characteristics of Candida albicans Bloodstream Isolates from Different Multilocus Sequence Typing Clades. |
| Q50128552 | Containment strategies to address the expanding threat of multidrug-resistant Candida auris |
| Q33812143 | Current perspective on emergence, diagnosis and drug resistance in Candida auris |
| Q36022880 | Detection of amphotericin B resistance in Candida haemulonii and closely related species by use of the Etest, Vitek-2 yeast susceptibility system, and CLSI and EUCAST broth microdilution methods |
| Q36014501 | Disseminated penicilliosis in a Korean human immunodeficiency virus infected patient from Laos |
| Q42708333 | Diversity of clinical isolates of Aspergillus terreus in antifungal susceptibilities, genotypes and virulence in Galleria mellonella model: Comparison between respiratory and ear isolates. |
| Q34492906 | Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris |
| Q36362961 | Echinocandin resistance in two Candida haemulonii isolates from pediatric patients |
| Q99709014 | Echinocandins as Biotechnological Tools for Treating Candida auris Infections |
| Q48721573 | Emergence of Candida auris: An International Call to Arms |
| Q38803537 | Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region |
| Q58598193 | Epidemiology, clinical characteristics, resistance, and treatment of infections by |
| Q89088418 | Evaluation of the efficacy of rezafungin, a novel echinocandin, in the treatment of disseminated Candida auris infection using an immunocompromised mouse model |
| Q34543358 | First hospital outbreak of the globally emerging Candida auris in a European hospital |
| Q36284852 | First report of a clinical isolate of Candida haemulonii in Brazil |
| Q55017741 | First reported case of multidrug-resistant Candida auris in Canada. |
| Q34196357 | First three reported cases of nosocomial fungemia caused by Candida auris |
| Q39092120 | Fluconazole resistance in Candida species: a current perspective |
| Q89355063 | From hidden outbreaks to epidemic emergencies: the threat associated with neglecting emerging pathogens |
| Q92058439 | Global Screening of Genomic and Transcriptomic Factors Associated with Phenotype Differences between Multidrug-Resistant and -Susceptible Candida haemulonii Strains |
| Q36106409 | Identification and Antifungal Susceptibility Profiles of Candida haemulonii Species Complex Clinical Isolates from a Multicenter Study in China |
| Q64084323 | Identification of Off-Patent Compounds That Present Antifungal Activity Against the Emerging Fungal Pathogen |
| Q40343987 | Identification of pathogenic rare yeast species in clinical samples: comparison between phenotypical and molecular methods |
| Q50061342 | Importation, Mitigation, and Genomic Epidemiology of Candida auris at a Large Teaching Hospital. |
| Q92039317 | In vitro antifungal activity of a novel topical triazole PC945 against emerging yeast Candida auris |
| Q90573021 | In vitro antifungal combination of flucytosine with amphotericin B, voriconazole, or micafungin against Candida auris shows no antagonism |
| Q104135019 | In vitro synergy of isavuconazole in combination with colistin against Candida auris |
| Q91711746 | In vivo Activity of Copper(II), Manganese(II), and Silver(I) 1,10-Phenanthroline Chelates Against Candida haemulonii Using the Galleria mellonella Model |
| Q64130194 | Insights into the Unique Nature of the East Asian Clade of the Emerging Pathogenic Yeast Candida auris |
| Q48054383 | Internal transcribed spacer region sequence analysis using SmartGene IDNS software for the identification of unusual clinical yeast isolates |
| Q89288908 | Invasive Candida auris infections in Kuwait hospitals: epidemiology, antifungal treatment and outcome |
| Q90146452 | Isolation of Candida auris from invasive and non-invasive samples of a patient suffering from vascular disease, Italy, July 2019 |
| Q55032754 | Low-Cost Tetraplex PCR for the Global Spreading Multi-Drug Resistant Fungus, Candida auris and Its Phylogenetic Relatives. |
| Q37535957 | Micafungin: a review of its use in the prophylaxis and treatment of invasive Candida infections in pediatric patients |
| Q36083696 | Molecular identification and amphotericin B susceptibility testing of clinical isolates of Aspergillus from 11 hospitals in Korea |
| Q36189719 | Molecular identification of Schizophyllum commune as a cause of allergic fungal sinusitis |
| Q35586995 | Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek |
| Q37664411 | Multidrug-Resistant Candida haemulonii and C. auris, Tel Aviv, Israel |
| Q39092162 | Multidrug-resistant endemic clonal strain of Candida auris in India. |
| Q57214733 | Multilocus Sequence Typing (MLST) Genotypes of Bloodstream Isolates in Korea: Association With Antifungal Resistance, Mutations in Mismatch Repair Gene (Msh2), and Clinical Outcomes |
| Q34372060 | New clonal strain of Candida auris, Delhi, India |
| Q36728707 | Non-albicans Candida species in blood stream infections in a tertiary care hospital at New Delhi, India |
| Q37929788 | Opportunistic fungal infections in the Asia-Pacific region |
| Q38404103 | Otomastoiditis caused by Candida auris: Case report and literature review |
| Q46423359 | Planktonic growth and biofilm formation profiles in Candida haemulonii species complex |
| Q46492873 | Primary deep cutaneous candidiasis caused by Candida duobushaemulonii in a 68-year-old man: the first case report and literature review. |
| Q39092215 | Rapid and Accurate Molecular Identification of the Emerging Multidrug-Resistant Pathogen Candida auris |
| Q30561825 | Reclassification of the Candida haemulonii complex as Candida haemulonii (C. haemulonii group I), C. duobushaemulonii sp. nov. (C. haemulonii group II), and C. haemulonii var. vulnera var. nov.: three multiresistant human pathogenic yeasts |
| Q28833536 | Resistance Mechanisms and Clinical Features of Fluconazole-Nonsusceptible Candida tropicalis Isolates Compared with Fluconazole-Less-Susceptible Isolates |
| Q34547546 | Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses |
| Q93166142 | Something wicked this way comes: What health care providers need to know about Candida auris |
| Q33909419 | Spectrum and prevalence of fungi infecting deep tissues of lower-limb wounds in patients with type 2 diabetes |
| Q40486070 | Susceptibility to antifungal agents and enzymatic activity of Candida haemulonii and Cutaneotrichosporon dermatis isolated from soft corals on the Brazilian reefs. |
| Q36249753 | Tenosynovitis caused by Scedosporium apiospermum infection misdiagnosed as an Alternaria species: a case report |
| Q49489254 | The Candida auris Alert: Facts and Perspectives |
| Q38949297 | The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation. |
| Q46255428 | The hidden pathogenic potential of environmental fungi |
| Q52597955 | Understanding echinocandin resistance in the emerging pathogen Candida auris. |
| Q60958254 | What Have We Learned About Its Mechanisms of Pathogenicity? |
Search more.